Bevacizumab/IrinotecanLack of efficacy: case report

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2024年 / 2024卷 / 1期

关键词：

D O I：

10.1007/s40278-024-66073-x

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：91 / 91

相关论文

共 50 条

[21] Bevacizumab/dexamethasone/temozolomideLack of efficacy: case report
Reactions Weekly, 2022, 1917 (1) : 129 - 129
[22] Axitinib/bevacizumab/sunitinibLack of efficacy: case report
Reactions Weekly, 2023, 1964 (1) : 86 - 86
[23] Bevacizumab/dexamethasone/pentoxifyllineLack of efficacy: case report
Reactions Weekly, 2024, 2034 (1) : 76 - 76
[24] Bevacizumab/carboplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2022, 1907 (1) : 110 - 110
[25] Bevacizumab/capecitabine/oxaliplatinLack of efficacy: case report
Reactions Weekly, 2024, 2025 (1) : 88 - 88
[26] Bevacizumab/doxorubicin liposomalLack of efficacy: case report
Reactions Weekly, 2020, 1833 (1) : 100 - 100
[27] Aflibercept/bevacizumab/infliximabLack of efficacy: case report
Reactions Weekly, 2022, 1913 (1) : 27 - 27
[28] Bevacizumab/lobaplatin/pemetrexedLack of efficacy: case report
Reactions Weekly, 2023, 1981 (1) : 94 - 94
[29] Bevacizumab/temozolomide/vemurafenibLack of efficacy: case report
Reactions Weekly, 2023, 1952 (1) : 106 - 106
[30] Bevacizumab/temozolomideThrombocytopenia and lack of efficacy: case report
Reactions Weekly, 2022, 1905 (1) : 126 - 126

← 1 2 3 4 5 →